- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x OXL: OXALATE ION(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.2: 11 residues within 4Å:- Chain A: F.204, Q.348, V.351, G.352, F.355, M.359
- Ligands: C14.3, D10.24, LPE.25, D12.26, LPE.64
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.204, A:V.351, A:V.351, A:F.355, A:F.355
POV.40: 9 residues within 4Å:- Chain A: F.255, F.466, I.469, G.470, F.487, I.488, I.491
- Ligands: LPE.39, D12.41
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.255, A:F.466, A:I.469, A:F.487, A:I.488, A:I.491
- Hydrogen bonds: A:G.470
POV.83: 13 residues within 4Å:- Chain B: F.204, I.209, Q.348, V.351, G.352, F.355, M.359
- Ligands: LPE.22, C14.23, C14.44, D10.66, LPE.67, D12.68
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:F.204, B:I.209, B:V.351, B:F.355, B:F.355, B:F.355, B:F.355
POV.84: 11 residues within 4Å:- Chain B: V.230, F.255, F.466, A.467, I.469, G.470, R.474, F.487, I.488
- Ligands: LPE.81, D12.82
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:V.230, B:F.255, B:F.466, B:A.467, B:I.469, B:F.487, B:I.488
- Hydrogen bonds: B:G.470
- 8 x C14: TETRADECANE(Non-covalent)
C14.3: 5 residues within 4Å:- Chain A: A.203, F.204, Q.348, F.355
- Ligands: POV.2
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:A.203, A:F.204, A:F.355
C14.7: 3 residues within 4Å:- Chain A: F.122, F.336, F.399
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.122, A:F.336
C14.23: 7 residues within 4Å:- Chain A: A.504, F.505, L.508
- Ligands: LPE.22, D10.66, LPE.67, POV.83
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:A.504, A:F.505, A:L.508
C14.35: 1 residues within 4Å:- Chain A: P.302
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:P.302
C14.44: 3 residues within 4Å:- Chain B: A.203, Q.348
- Ligands: POV.83
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:A.203, B:Q.348
C14.48: 3 residues within 4Å:- Chain B: F.122, F.336, F.399
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:F.122, B:F.336
C14.65: 7 residues within 4Å:- Chain B: L.493, A.501, A.504, F.505
- Ligands: D10.24, LPE.25, LPE.64
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.493, B:A.504
C14.77: 1 residues within 4Å:- Chain B: P.302
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:P.302
- 16 x D12: DODECANE(Non-covalent)(Non-functional Binders)
D12.4: 5 residues within 4Å:- Chain A: I.199, T.341, P.342, V.344
- Ligands: LPE.5
Ligand excluded by PLIPD12.9: 2 residues within 4Å:- Chain A: L.433, L.437
Ligand excluded by PLIPD12.21: 7 residues within 4Å:- Chain A: F.255, L.258, Y.259, F.262, S.263
- Ligands: D10.20, CLR.42
Ligand excluded by PLIPD12.26: 5 residues within 4Å:- Chain A: L.207, R.208, F.211
- Chain B: F.516
- Ligands: POV.2
Ligand excluded by PLIPD12.32: 4 residues within 4Å:- Chain A: L.75, Y.78, L.80
- Ligands: D10.33
Ligand excluded by PLIPD12.34: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD12.36: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD12.41: 4 residues within 4Å:- Chain A: I.469, W.473, I.484
- Ligands: POV.40
Ligand excluded by PLIPD12.45: 5 residues within 4Å:- Chain B: I.199, T.341, P.342, V.344
- Ligands: LPE.46
Ligand excluded by PLIPD12.50: 1 residues within 4Å:- Chain B: L.433
Ligand excluded by PLIPD12.62: 4 residues within 4Å:- Chain B: Y.259, S.263
- Ligands: D10.61, CLR.63
Ligand excluded by PLIPD12.68: 6 residues within 4Å:- Chain A: F.516
- Chain B: L.207, R.208, I.209, F.211
- Ligands: POV.83
Ligand excluded by PLIPD12.74: 4 residues within 4Å:- Chain B: L.75, Y.78, L.80
- Ligands: D10.75
Ligand excluded by PLIPD12.76: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD12.78: 1 residues within 4Å:- Chain B: P.298
Ligand excluded by PLIPD12.82: 2 residues within 4Å:- Chain B: W.473
- Ligands: POV.84
Ligand excluded by PLIP- 14 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
LPE.5: 11 residues within 4Å:- Chain A: I.199, L.202, A.203, I.206, P.339, T.341, P.342, I.394, V.398
- Ligands: D12.4, D10.6
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:I.199, A:L.202, A:A.203, A:I.206, A:I.394, A:V.398
LPE.13: 10 residues within 4Å:- Chain A: V.309, A.312, G.313, Y.316, V.435, I.439, F.441, L.442
- Ligands: D10.11, D10.12
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:A.312, A:Y.316, A:Y.316, A:V.435, A:I.439, A:L.442, A:L.442, A:L.442
- pi-Cation interactions: A:F.441
LPE.15: 5 residues within 4Å:- Chain A: M.307, I.310, R.323, F.324
- Ligands: LPE.16
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.310
- Hydrogen bonds: A:R.323
LPE.16: 14 residues within 4Å:- Chain A: I.270, A.271, V.274, T.275, I.278, M.307, I.310, A.311, V.314, F.320, R.323, F.324, K.325
- Ligands: LPE.15
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:I.270, A:I.278, A:I.310, A:V.314, A:F.320, A:F.324
- Salt bridges: A:K.325
LPE.22: 7 residues within 4Å:- Chain A: K.256, M.485, I.488, L.493
- Ligands: C14.23, CLR.42, POV.83
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.488, A:L.493
- Salt bridges: A:K.256
LPE.25: 19 residues within 4Å:- Chain A: K.158, I.209, F.211, V.212, Y.215, G.352, D.353, G.356, M.359, G.496, L.497, A.500, V.503
- Chain B: L.508, F.512, Q.515
- Ligands: POV.2, D10.24, C14.65
10 PLIP interactions:3 interactions with chain B, 7 interactions with chain A- Hydrophobic interactions: B:L.508, B:F.512, B:F.512, A:I.209, A:F.211, A:V.212, A:Y.215, A:Y.215, A:M.359, A:V.503
LPE.39: 7 residues within 4Å:- Chain A: L.233, V.234, L.258, M.464, A.467
- Ligands: D10.38, POV.40
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.233, A:V.234, A:L.258
LPE.46: 11 residues within 4Å:- Chain B: I.199, L.202, A.203, I.206, P.339, T.341, P.342, I.394, V.398
- Ligands: D12.45, D10.47
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:I.199, B:L.202, B:A.203, B:I.206, B:I.394, B:V.398
LPE.54: 13 residues within 4Å:- Chain B: I.96, F.305, V.309, A.312, G.313, Y.316, V.435, F.441, L.442, L.443, P.445
- Ligands: D10.52, D10.53
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:I.96, B:F.305, B:V.309, B:V.309, B:A.312, B:Y.316, B:Y.316, B:V.435, B:L.442, B:L.443, B:P.445
- pi-Cation interactions: B:F.441
LPE.56: 3 residues within 4Å:- Chain B: R.323
- Ligands: LPE.57, D10.58
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.323, B:R.323
- Salt bridges: B:R.323
LPE.57: 12 residues within 4Å:- Chain B: I.270, A.271, T.275, I.278, M.307, I.310, A.311, V.314, F.320, F.324, K.325
- Ligands: LPE.56
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:I.270, B:A.271, B:I.278, B:I.310, B:A.311, B:V.314, B:F.320, B:F.324, B:F.324
- Salt bridges: B:K.325
LPE.64: 9 residues within 4Å:- Chain B: V.252, K.256, M.485, I.488, V.492, L.493
- Ligands: POV.2, CLR.63, C14.65
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:I.488, B:I.488, B:V.492, B:L.493
- Salt bridges: B:K.256
LPE.67: 16 residues within 4Å:- Chain A: F.512, Q.515
- Chain B: I.209, F.211, V.212, Y.215, G.352, D.353, G.356, G.496, L.497, A.500, V.503
- Ligands: C14.23, D10.66, POV.83
9 PLIP interactions:8 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:I.209, B:F.211, B:F.211, B:V.212, B:Y.215, B:Y.215, B:V.503, A:F.512
- Hydrogen bonds: B:D.353
LPE.81: 3 residues within 4Å:- Chain B: L.233, M.464
- Ligands: POV.84
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.233
- 38 x D10: DECANE(Non-covalent)(Non-functional Binders)
D10.6: 3 residues within 4Å:- Chain A: P.339, I.394
- Ligands: LPE.5
Ligand excluded by PLIPD10.8: 2 residues within 4Å:- Chain A: F.121, I.125
Ligand excluded by PLIPD10.10: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD10.11: 3 residues within 4Å:- Chain A: I.439
- Ligands: D10.12, LPE.13
Ligand excluded by PLIPD10.12: 2 residues within 4Å:- Ligands: D10.11, LPE.13
Ligand excluded by PLIPD10.14: 1 residues within 4Å:- Chain A: V.309
Ligand excluded by PLIPD10.17: 1 residues within 4Å:- Chain A: V.274
Ligand excluded by PLIPD10.18: 1 residues within 4Å:- Chain A: L.277
Ligand excluded by PLIPD10.19: 1 residues within 4Å:- Chain A: I.265
Ligand excluded by PLIPD10.20: 2 residues within 4Å:- Chain A: I.265
- Ligands: D12.21
Ligand excluded by PLIPD10.24: 7 residues within 4Å:- Chain A: A.500, V.503, L.507
- Chain B: A.504
- Ligands: POV.2, LPE.25, C14.65
Ligand excluded by PLIPD10.27: 3 residues within 4Å:- Chain A: I.64, L.68, R.208
Ligand excluded by PLIPD10.28: 1 residues within 4Å:- Chain A: P.58
Ligand excluded by PLIPD10.29: 4 residues within 4Å:- Chain A: V.65, L.66, F.69
- Ligands: D10.30
Ligand excluded by PLIPD10.30: 4 residues within 4Å:- Chain A: A.72, P.76, F.129
- Ligands: D10.29
Ligand excluded by PLIPD10.31: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD10.33: 5 residues within 4Å:- Chain A: I.92, I.427, I.430, I.431
- Ligands: D12.32
Ligand excluded by PLIPD10.37: 3 residues within 4Å:- Chain A: L.277, L.280, S.284
Ligand excluded by PLIPD10.38: 4 residues within 4Å:- Chain A: L.233, L.280, K.460
- Ligands: LPE.39
Ligand excluded by PLIPD10.47: 1 residues within 4Å:- Ligands: LPE.46
Ligand excluded by PLIPD10.49: 2 residues within 4Å:- Chain B: F.121, I.125
Ligand excluded by PLIPD10.51: 1 residues within 4Å:- Ligands: D10.52
Ligand excluded by PLIPD10.52: 4 residues within 4Å:- Chain B: I.439
- Ligands: D10.51, D10.53, LPE.54
Ligand excluded by PLIPD10.53: 2 residues within 4Å:- Ligands: D10.52, LPE.54
Ligand excluded by PLIPD10.55: 1 residues within 4Å:- Chain B: V.309
Ligand excluded by PLIPD10.58: 2 residues within 4Å:- Chain B: V.274
- Ligands: LPE.56
Ligand excluded by PLIPD10.59: 1 residues within 4Å:- Chain B: L.277
Ligand excluded by PLIPD10.60: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD10.61: 2 residues within 4Å:- Chain B: F.262
- Ligands: D12.62
Ligand excluded by PLIPD10.66: 5 residues within 4Å:- Chain B: A.500, L.507
- Ligands: C14.23, LPE.67, POV.83
Ligand excluded by PLIPD10.69: 2 residues within 4Å:- Chain B: L.68, R.208
Ligand excluded by PLIPD10.70: 1 residues within 4Å:- Chain B: P.58
Ligand excluded by PLIPD10.71: 6 residues within 4Å:- Chain B: K.62, V.65, L.66, F.69, A.72
- Ligands: D10.72
Ligand excluded by PLIPD10.72: 3 residues within 4Å:- Chain B: L.75
- Ligands: D10.71, D10.73
Ligand excluded by PLIPD10.73: 1 residues within 4Å:- Ligands: D10.72
Ligand excluded by PLIPD10.75: 5 residues within 4Å:- Chain B: I.88, I.427, I.430, I.431
- Ligands: D12.74
Ligand excluded by PLIPD10.79: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPD10.80: 3 residues within 4Å:- Chain B: L.233, L.280, L.456
Ligand excluded by PLIP- 2 x CLR: CHOLESTEROL(Non-covalent)
CLR.42: 7 residues within 4Å:- Chain A: V.252, F.255, K.256, I.488, V.492
- Ligands: D12.21, LPE.22
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.252, A:F.255, A:K.256, A:I.488, A:V.492
CLR.63: 5 residues within 4Å:- Chain B: F.255, K.256, V.492
- Ligands: D12.62, LPE.64
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:F.255, B:F.255, B:F.255, B:K.256, B:V.492
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, X. et al., Cryo-EM structure of human DRA (SLC26A3) bound with oxalate. To Be Published
- Release Date
- 2025-05-14
- Peptides
- Chloride anion exchanger: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x OXL: OXALATE ION(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 8 x C14: TETRADECANE(Non-covalent)
- 16 x D12: DODECANE(Non-covalent)(Non-functional Binders)
- 14 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 38 x D10: DECANE(Non-covalent)(Non-functional Binders)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, X. et al., Cryo-EM structure of human DRA (SLC26A3) bound with oxalate. To Be Published
- Release Date
- 2025-05-14
- Peptides
- Chloride anion exchanger: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.